ANTHONY C HOOPER Insider Trading $BMY BRISTOL MYERS SQUIBB CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTHONY C HOOPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTHONY C HOOPER. ANTHONY C HOOPER is EVP, Global Commercial Ops. in AMGEN INC ($AMGN) and President US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY) and Director in MANNKIND CORP ($MNKD) and Director in BeiGene, Ltd. ($BGNE).
ANTHONY C HOOPER in BRISTOL MYERS SQUIBB CO
Trading Symbol: BMYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANTHONY C HOOPER: President US Pharmaceuticals
Holdings: 102,331 shares
Current Value: $5,286,419
Latest Transaction: Mar 06 2008
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANTHONY C HOOPER in BRISTOL MYERS SQUIBB CO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, BGNE, BMY, MNKD
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2008 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | A | 0.00 | 13,077 | 0 | 13,077 | |
Mar 06 2008 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | A | 22.14 | 171,495 | 3,796,899 | 171,495 | |
Mar 04 2008 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 22.61 | 1,178 | 26,635 | 102,331 | 103.5 K to 102.3 K (-1.14 %) |
Mar 04 2008 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 22.61 | 1,038 | 23,469 | 103,509 | 104.5 K to 103.5 K (-0.99 %) |
Sep 12 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 0.00 | 3,871 | 0 | 104,558 | 108.4 K to 104.6 K (-3.57 %) |
Jun 21 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 31.23 | 2,431 | 75,920 | 95,549 | 98 K to 95.5 K (-2.48 %) |
Jun 01 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | M | 28.90 | 30,000 | 867,000 | 0 | |
Jun 01 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 30.12 | 443 | 13,343 | 97,980 | 98.4 K to 98 K (-0.45 %) |
Jun 01 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 30.12 | 28,785 | 867,004 | 98,423 | 127.2 K to 98.4 K (-22.63 %) |
Jun 01 2007 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Buy | M | 28.90 | 30,000 | 867,000 | 127,208 | 97.2 K to 127.2 K (+30.86 %) |
Jun 22 2006 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 25.48 | 2,431 | 61,942 | 113,165 | 115.6 K to 113.2 K (-2.10 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | A | 22.73 | 78,750 | 1,789,988 | 78,750 | |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 22.73 | 1,862 | 42,323 | 115,596 | 117.5 K to 115.6 K (-1.59 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Grant | A | 22.73 | 5,107 | 116,082 | 117,458 | 112.4 K to 117.5 K (+4.55 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Grant | A | 22.73 | 18,900 | 429,597 | 112,351 | 93.5 K to 112.4 K (+20.22 %) |
Jul 12 2005 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 24.82 | 639 | 15,860 | 68,451 | 69.1 K to 68.5 K (-0.92 %) |
Sep 21 2005 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Grant | A | 0.00 | 25,000 | 0 | 93,451 | 68.5 K to 93.5 K (+36.52 %) |
Jun 22 2005 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 0.00 | 2,430 | 0 | 69,090 | 71.5 K to 69.1 K (-3.40 %) |
Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | A | 25.45 | 55,833 | 1,420,950 | 55,833 | |
Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Grant | A | 0.00 | 9,306 | 0 | 71,520 | 62.2 K to 71.5 K (+14.96 %) |
Jul 12 2004 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Payment of Exercise | F | 24.19 | 587 | 14,200 | 62,214 | 62.8 K to 62.2 K (-0.93 %) |
Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Option Exercise | A | 28.11 | 63,333 | 1,780,291 | 63,333 | |
Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | HOOPER ANTHONY C | President US Pharma ... | Grant | A | 0.00 | 10,556 | 0 | 62,801 | 52.2 K to 62.8 K (+20.20 %) |
Page: 1